Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8.72 million versus the consensus estimate of $4.62 million.

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.